Implantable Devices for Drug Delivery with Reduced Burst Release
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,678,400 | Implantable Devices for Drug Delivery with Reduced Burst Release In force · High confidence UsedRemaining | Fedson, Inc. | In force | High confidence | ||
| US 12,678,401 | Implantable Devices for Drug Delivery with Reduced Burst Release In force · High confidence | Titan Pharmaceuticals, Inc. | In force | High confidence | ||
| Application 16/338,962 | Implantable Devices for Drug Delivery with Reduced Burst Release Abandoned Abandoned Oct 20, 2023 | Fedson, Inc. | Abandoned | Abandoned Oct 20, 2023 |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Titan Pharmaceuticals, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.